Company: LCTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0000950170-25-060090
Chunk: 110

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 110
---
xies"), as proxies and true and lawful attorneys-in-fact of the undersigned, with full power of substitution, and hereby authorizes them, and each or either of them, to represent and vote all the common shares which the undersigned is entitled to vote at the Annual Meeting of Shareholders of Lineage Cell Therapeutics, Inc. (the "Company") to be held on June 26, 2025 at 8:00 a.m. Pacific Time, or any adjournment or postponement thereof, as designated on the reverse side of this proxy card, revoking any other proxy heretofore given. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is given, this proxy will be voted in accordance with the recommendations of the board of directors. You are encouraged to specify your choice by marking the appropriate box (SEE REVERSE SIDE) but you need not mark any box if you wish to vote in accordance with the board of directors’ recommendations. The Named Proxies cannot vote your shares unless you sign the reverse side and return this card. PLEASE BE SURE TO MARK, SIGN AND DATE THIS PROXY CARD ON THE REVERSE SIDE Copyright © 2025 BetaNXT, Inc. or its affiliates. All Rights Reserved

Lineage Cell Therapeutics, Inc. Annual Meeting of Shareholders Please make your marks like this: THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR EACH DIRECTOR NOMINEE LISTED AND FOR ON PROPOSALS 2, 3 AND 4. BOARD OF DIRECTORS PROPOSAL YOUR VOTE RECOMMENDS 1. To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified. FOR WITHHOLD 1.01 Dipti Amin FOR #P2

# #P2# 1.02 Deborah Andrews FOR #P3# #P3# 1.03 Neal C. Bradsher FOR #P4# #P4# 1.04 Brian M. Culley FOR #P5# #P5# 1.05 Anula Jayasuriya FOR #P6# #P6# 1.06 Michael H. Mulroy FOR #P7# #P7# 1.07 Angus C. Russell FOR #P8# #P8# FOR AGAINST ABSTAIN 2. To ratify the appointment of Moss Adams LLP as our